← Leaderboards
Hamid Moradi
University Of California-Irvine
$185,622
Attributed
$185,622
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $63K · FY2009–20$100K$75K$50K$25K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$185,622 · 1
VA$0 · 1
By mechanism
F32$185,622 · 1
IK2$0 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of California-Irvine
Same institution · by research overlap
- Daniela Annenelie Bota$3,732,045
- Kim Green$36,308,762
- Wayne W Poon$7,008,264
- Craig E Stark$15,872,981
- Mathew Mark Blurton-Jones$14,315,430
Others in their field
Top investigators on “Pathway Interactions”
- David Heimbrook · Leidos Biomedical Research, Inc.$202,777,247
- Ralph Parchment · Leidos Biomedical Research, Inc.$146,974,543
- David R. Weir · University Of Michigan At Ann Arbor$129,316,139
- Daniel Ernest Ford · Johns Hopkins University$108,075,637
- David W Simpson · University Of Southern California$88,046,235
- Charles D. Blanke · Oregon Health And Science University$86,571,896
Research focus
Pathway InteractionsSerumInflammationOxidative StressPreventionReverse Cholesterol TransportDialysis PatientsHigh Density LipoproteinsIn VitroMeasurementPlayPrevalenceAtherosclerosisProductionBaseCell Culture TechniquesDialysis ProcedureDisease SusceptibilityApolipoprotein A-IChronic Kidney FailureCardiovascular Risk FactorCardiovascular SystemAreaResearch Study
Grant awards (9)
HDL function and mortality in end stage renal disease$0
IK2 · FY2020 · VA · contact PI
HDL function and mortality in end stage renal disease$0
IK2 · FY2019 · VA · contact PI
HDL function and mortality in end stage renal disease$0
IK2 · FY2018 · VA · contact PI
HDL function and mortality in end stage renal disease$0
IK2 · FY2017 · VA · contact PI
HDL function and mortality in end stage renal disease$0
IK2 · FY2016 · VA · contact PI
HDL function and mortality in end stage renal disease$0
IK2 · FY2015 · VA · contact PI
Mechanisms involved in uremic toxin mediated down regulation of ApoA-I expression$62,980
F32 · FY2011 · DK · contact PI
Mechanisms involved in uremic toxin mediated down regulation of ApoA-I expression$61,688
F32 · FY2010 · DK · contact PI
Mechanisms involved in uremic toxin mediated down regulation of ApoA-I expression$60,954
F32 · FY2009 · DK · contact PI